OTCMarketsExpert

OTCMarketsExpert 21 views ・

Technically it looks like a bottom may be in and a reversal opportunity is in play. $1.068 has acted as support for multiple trading days. Macd has now crossed and reversed course, whie the histogram is bullish. Possibly a move above the middle Bollinger Band will ignite a rally. COMPANY PROFILE Americann, Inc. is engaged in the development of medical...

OTCMarketsExpert 151 views ・

Long trade setup looking very bullish. Fundamentals and technicals align for a nice trade opportunity. Indicators have reversed and remained positive. Good risk reward on long above $17 Wait for a MACD cross possibly to confirm bullish sentiment COMPANY PROFILE Charlotte's Web Holdings, Inc. engages in the production and distribution of hemp-based, cannabinoid...

OTCMarketsExpert 98 views ・

Maybe not exactly what they Bears expected to happen but Curaleaf Management have actually turned a bad situation into a positive, rather than fighting the FDA, a warm welcome has been extended a proactive measures taken to comply. The company is in a high growth trajectory and maybe see the FDA involvement as the start of washing the bad actors out of the retail...

OTCMarketsExpert 82 views ・

Despite the entire Cannabis sector been dragged down by NYSE:CTST, Veritas Farms has shown signs of what could be a very profitable reversal. As highlighted on the chart, several positive factors are in play and depending on your risk tolerance we have listed 2 possible entry points for a long trade. NEWS HEADLINES FORT LAUDERDALE, FL, Jul 24, 2019 (GLOBE...

OTCMarketsExpert 50 views ・

======================== SMSI (Smith Micro Software Inc.) Alert Price: $3.36 Float: 22.31M 12-Month Consensus Price Target: $5.00 Investor Presentation Company Website | Recent News ======================== Members, Smith Micro Software (SMSI) is expected to deliver a year-over-year increase in earnings on higher revenues when it reports results for...

OTCMarketsExpert 374 views ・

Technically or fundamentally this is by no means a thing of beauty, now trading a ridiculously low P/E ratio it may be a case of it is so bad it may be good. We think there is a nice opportunity for a long trade entry as indicators and volume signal a sustained a reversal, rather than a brief bounce. AVERAGE ANALYSTS PRICE TARGET $2.50 AVERAGE...

OTCMarketsExpert 154 views ・

If you are believer in the Crypto asset class, OTC:GBTCmay be a very good proposition for you, given the hourly and daily volatility in the market, it can often lead to panic selling or buying. They advantage of such a trust if that it takes the emotion out of your investment and places that emotion with someone qualified to handle the swings involved in crypto...

OTCMarketsExpert 59 views ・

===================== ISBG (International Spirits & Wellness Holdings, Inc.) Alert Price: $0.0012 Float: 54.4M Chart Analysis Website | Recent News ======================== Members, We hope you have enjoyed the up to +135% in realistic profit that our past two trade ideas have delivered. We plan on keeping the good times rolling with a fresh trade idea...

OTCMarketsExpert 37 views ・

Technically the chart of OTC:QMED is starting to look more bullish since the start of July, possibly a base is formed and a bottoming complete. Significant resistance will hamper the recovery, but if considering a long maybe a break of the downtrend in price and RSI would be a buy signal. AVERAGE ANALYSTS PRICE TARGET $2 AVERAGE ANALYSTS RECOMMENDATION HOLD P/E...

OTCMarketsExpert 211 views ・

Hotstock expect more upside after securing $600 million equity investment proposal. Very likely that analyst upgrades will follow and entice new money into the stock with the promise of growth and expansion. “I am very proud today to share with all Nemaska Lithium stakeholders, the positive outcome of months of thorough review of alternatives and of discussions...

OTCMarketsExpert 23 views ・

Bristol-Myers Squibb ( BMY ), Bayer and Ono Pharmaceutical (OPHLY) have entered into a clinical collaboration agreement to evaluate the combination of Bayer's kinase inhibitor Stivarga and Bristol-Myers Squibb's / Ono's anti-PD-1 immune checkpoint inhibitor, Opdivo in patients with micro-satellite stable metastatic colorectal cancer, the most common form of mCRC....

OTCMarketsExpert 205 views ・

Google has been on a tear from the Dec lows, it has now hit the 786 retrace and has sold of quite quickly as a result. It had a initial inverse H@S on the macd and then on price action which provided a lovely opportunity to go long. Due to the increased fear of regulation on Big Tech and social media's role in the New Zealand massacre, sentiment has changed...